Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Matrix metalloprotease regulation of neuropathic pain
Trends in Pharmacological Sciences, 07/01/09
Ji RR et al. - This recent study has shown that neuropathic pain development in the early and late phase requires MMP-9 and MMP-2, respectively. Inhibition of MMP-9 or MMP-2 might provide a new strategy for the prevention and treatment of neuropathic pain.
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Milnacipran: Beyond a Role of Antidepressant
Clinical Neuropharmacology, 12/14/09
Zonisamide in the treatment of epilepsy
Expert Opinion in Pharmacotherapy, 12/14/09
Treatment strategies for dystonia
Expert Opinion in Pharmacotherapy, 12/14/09